Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas

Supplemental material

• Supplemental file 1 -

  Fig. S1 (Read coverage across the EBV genome showing high coverage of the BART/RPMS1 region of the genome.)

  Fig. S2 (Genome browser view of the LMP2 locus for 25 EBV-positive TCGA biopsy specimens.)

  Legends for Tables S1 to S3.

  PDF, 2.7M

• Supplemental file 2 -

  Table S1 (Counts for human- and virus-mapped RNA-seq reads for TCGA tumor and healthy specimens.)

  XLSX, 27K

• Supplemental file 3 -

  Table S2 (Counts for human- and virus-mapped WXS reads for TCGA tumor specimens.)

  XLSX, 33K

• Supplemental file 4 -

  Table S3 (Counts for human- and virus-mapped RNA-seq reads for CCLE GC cell lines.)

  XLSX, 10.0K